Precision Oncology News

Precision Oncology Business News

Financial news, mergers and acquisitions, partnerships, and alliances.

JP Morgan Healthcare, Day 3: Puma Biotechnology, Natera

Puma provided an update on its plan for Nerlynx and Natera discussed the cancer trials its Signatera test is being used in.

JP Morgan Healthcare, Day 1: Agios Pharmaceuticals, Clovis Oncology, Mirati Therapeutics, and More

Among the firms presenting, drugmakers, speciality biotechs, and genetic testing firms provided an update on their precision oncology development programs.

Qiagen, Amgen Collaborate to Develop CDx for Investigational NSCLC Drug

The companies will develop tissue-based companion diagnostics for Amgen's investigational treatment AMG 510 for non-small cell lung cancer.

Adaptive Biotechnologies, Genentech Partner on MRD Testing in Venetoclax Clinical Trial

Genentech will use Adaptive's ClonoSeq assay for MRD testing in a CLL study. Adaptive will receive upfront and sample testing payments of undisclosed amounts.

Oncocyte to Acquire Insight Genetics for $12M

Insight's portfolio includes a gene expression-based immuno-oncology assay for therapy response prediction.

Jan 08, 2020

Personal Genome Diagnostics, Mayo Clinic to Collaborate on Cancer Genomic Tests

Jan 02, 2020

Precision Oncology in 2019: Growing Options Highlight Gaps in Healthcare Delivery System

Premium

Jan 02, 2020

Japanese Regulator Approves Foundation Medicine CDx for Roche's Rozlytrek in Lung Cancer

Dec 17, 2019

Immune Therapeutics Acquires Aletheia to Develop Precision Oncology Medicines

Dec 06, 2019

Roche Ending Partnership With Syapse

Dec 03, 2019

Palmetto Issues Final LCD for Decipher Biosciences Prostate Cancer Test

Dec 02, 2019

Fujitsu Laboratories, Aichi Cancer Center to Develop AI-Based Tech for Cancer Genome Data Analysis

Nov 19, 2019

HalioDx, Kite Pharma Extend Biomarker Collaboration

Nov 07, 2019

Lucence Diagnostics, MEDx Partner on Companion Diagnostic Cancer Tests in China

Nov 06, 2019

Merck, Promega Collaborate to Develop MSI CDx for Keytruda

Oct 30, 2019

Exact Sciences Preparing to Launch Improved Cologuard, Liver Cancer Test

Premium

Oct 14, 2019

Exact Sciences, Mayo Clinic Launch Real-World Impact Study for Cologuard

Oct 10, 2019

Biofidelity Awarded £500K Innovate UK Grant to Develop Noninvasive MDx Tools

Oct 07, 2019

Gestalt Diagnostics Enters Collaborations on Cancer Pathology Testing

Oct 04, 2019

Adding RNA-Seq, Ambry Genetics Expects to Reduce VUS Results in Hereditary Cancer Tests

Premium

Oct 03, 2019

Predictive Oncology Prices $3.2M Public Offering

Oct 02, 2019

Agilent Technologies PD-L1 IHC Assay Approved by China Regulators

Oct 02, 2019

SEngine Precision Medicine Raises $5.1M in Series A Financing

Sep 10, 2019

SEngine Precision Medicine, Atomwise Partner on Personalized Cancer Drug Development

Aug 26, 2019

Freenome, ADC Therapeutics Sign Biomarker Development Deal